Enteric GFAP expression and phosphorylation in Parkinson's disease

Area of Science:

• Neuroscience
• Gastroenterology
• Cell Biology

Background:

• Enteric glial cells (EGCs) resemble central nervous system astrocytes and express glial fibrillary acidic protein (GFAP).
• Parkinson's disease (PD) involves α-synuclein accumulation in enteric neurons, suggesting gut involvement.
• Changes in GFAP expression and phosphorylation are linked to neurodegeneration.

Purpose of the Study:

• To investigate enteric glial cell reactivity in Parkinson's disease (PD) by examining GFAP expression and phosphorylation in colonic biopsies.
• To differentiate enteric glial responses in PD from those in atypical parkinsonism (MSA, PSP).

Main Methods:

• Western blot analysis of GFAP expression and phosphorylation levels in colonic biopsies.
• Real-time PCR to identify specific GFAP isoforms in EGCs.
• Inclusion of patients with PD, MSA, PSP, and age-matched healthy controls.

Main Results:

• GFAPκ was identified as the primary GFAP isoform in EGCs.
• PD patients exhibited significantly higher GFAP expression compared to controls.
• PD patients showed significantly lower GFAP phosphorylation at serine 13 compared to controls.
• No significant changes in GFAP expression or phosphorylation were observed in MSA or PSP patients.

Conclusions:

• Enteric glial cells in PD patients are reactive, characterized by GFAP overexpression and hypophosphorylation.
• Enteric glial reaction is specific to PD and not observed in atypical parkinsonism (MSA, PSP).
• These findings support the role of the enteric nervous system in the pathophysiology of Parkinson's disease.